内部人交易记录
董事基于 3 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the detailed record of transactions filed by Feinberg Peter, 董事. Director active across 2 companies, notably Immuneering Corp. Aggregated, 12 reports have been logged. Split: 10 buys · 0 sell. Total volume traded: €647k. Activity tracked since 13 September 2021. The latest transaction was disclosed on 12 January 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Feinberg Peter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
20,000 股@ US$4.345211.6% 占其流量Class A Common StockSEC:0001790340-26-000008:0
7,500 股@ US$6.677.5% 占其流量Class A Common StockSEC:0001790340-25-000127:0
7,500 股@ US$7.03078.5% 占其流量Class A Common StockSEC:0001790340-25-000119:0
5,000 股@ US$7.185.8% 占其流量Class A Common StockSEC:0001790340-25-000117:0
25,000 股@ US$2.527512.1% 占其流量Class A Common StockSEC:0001790340-25-000083:0
40,247 股0Ordinary SharesSEC:0001062993-24-009929:0
25,000 股@ US$2.54859.7% 占其流量Class A Common StockSEC:0001790340-24-000042:0
45,024 股@ US$2.306715.8% 占其流量Class A Common StockSEC:0001790340-24-000028:0
6,667 股@ US$6.756.4% 占其流量Class A Common StockSEC:0001415889-22-003061:0
4,750 股@ US$24.44515.3% 占其流量Class A Common StockSEC:0001415889-21-004512:0
5,750 股@ US$21.512616.2% 占其流量Class A Common StockSEC:0001415889-21-004407:0
133,572 股Class A Common StockSEC:0001104659-21-099742:0
About Feinberg Peter
Feinberg Peter is Administrateur at Immuneering Corp and Notable Labs, Ltd. A total of 12 filings are recorded. Across the 12 most recent filings we hold, they cover the period from 2021-08-04 to 2026-01-14, with EUR 646936 of buys and EUR 0 of sells, and the most frequent transaction nature is Acquisition.